Article Information
History
- August 10, 2021.
Article Versions
- You are currently viewing Version 1 of this article (August 10, 2021 - 07:32).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Byron J. SmithAB,
- Yvette PicenoC,
- Martin ZydekD,
- Bing ZhangD,
- Lara Aboud SyrianiE,
- Jonathan P. TerdimanD,
- Zain KassamF,
- Averil MaG,
- Susan V. LynchDH,
- Katherine S. PollardABI and
- Najwa El-NachefD,*
- AThe Gladstone Institute of Datascience and Biotechnology, San Francisco, CA
- BDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA
- CSymbiome, Inc., San Francisco, CA
- DDivision of Gastroenterology, University of California, San Francisco, CA
- ECollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA
- FFinch Therapeutics, Somerville, MA
- GDepartment of Medicine, University of California, San Francisco, CA
- HBenioff Center for Microbiome Medicine, University of California, San Francisco, CA
- IChan-Zuckerberg Biohub, San Francisco, CA
- ↵*Corresponding authors: katherine.pollard{at}gladstone.ucsf.edu, najwa.elnachef{at}ucsf.edu
Posted August 10, 2021.
Clinical efficacy and increased donor strain engraftment after antibiotic pretreatment in a randomized trial of ulcerative colitis patients receiving fecal microbiota transplant
